Emily Collier, MD
Assistant Professor AdjunctCards
Titles
Heme-Onc Medicine Fellow, Medical Oncology
Contact Info
About
Titles
Assistant Professor Adjunct
Heme-Onc Medicine Fellow, Medical OncologyAppointments
Medical Oncology
Assistant Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- Internal Medicine Resident
- Brigham and Women's Hospital (2012)
- MD
- Harvard Medical School, Harvard-MIT Health Sciences and Technology Program (2009)
- BS
- Yale University School of Medicine, Molecular Cellular and Developmental Biology (2002)
Research
Clinical Trials
Current Trials
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
HIC ID2000032879RoleSub InvestigatorPrimary Completion Date12/31/2026Recruiting ParticipantsThe CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
HIC ID2000030282RoleSub InvestigatorPrimary Completion Date01/01/2028Recruiting ParticipantsLUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)
HIC ID2000025282RoleSub InvestigatorPrimary Completion Date01/28/2029Recruiting ParticipantsAdjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
HIC ID1507016130RoleSub InvestigatorPrimary Completion Date09/28/2026Recruiting Participants